Valuation APTOCROM Inc.

Stocks

End-of-day quote Korea S.E. 28/09/2026			5-day change	1st Jan Change
1,856.00 ^KRW	+0.11%		+0.05%	-62.88%

23/09	Aprogen Medicines Inc. announced that it has received KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc.	CI
03/09	Aprogen Medicines Inc. announced that it expects to receive KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	132,471	125,151	66,950	51,548	104,593	55,188
Change	-	-5.53%	-46.5%	-23.01%	102.9%	-47.23%
Enterprise Value (EV) ¹	101,306	69,004	-14,380	55,057	79,526	37,996
Change	-	-31.89%	-120.84%	482.87%	44.44%	-52.22%
P/E	12x	47.2x	-11.9x	24x	-2.12x	-9.5x
PBR	0.57x	0.56x	0.34x	0.31x	0.35x	0.18x
PEG	-	-0.6x	0x	-0x	0x	0.1x
Capitalization / Revenue	12.8x	14.9x	6.98x	3.22x	6.38x	5.63x
EV / Revenue	9.82x	8.2x	-1.5x	3.44x	4.85x	3.87x
EV / EBITDA	4,671x	-31.8x	1.22x	-2.69x	83.9x	-2.32x
EV / EBIT	-270x	-26.8x	1.19x	-2.62x	154x	-2.27x
EV / FCF	-1.98x	5.77x	-0.46x	13.1x	-32.9x	-1.9x
FCF Yield	-50.6%	17.3%	-216%	7.65%	-3.04%	-52.7%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	6,200	1,484	-3,140	648.5	-4,924	-526.5
Distribution rate	-	-	-	-	-	-
Net sales ¹	10,319	8,416	9,598	16,007	16,400	9,807
EBITDA ¹	21.69	-2,167	-11,810	-20,454	947.7	-16,372
EBIT ¹	-375.2	-2,579	-12,099	-21,004	517.3	-16,737
Net income ¹	11,084	2,650	-5,607	4,304	-28,094	-5,559
Net Debt ¹	-31,165	-56,147	-81,330	3,509	-25,067	-17,192
Reference price ²	74,200.00	70,100.00	37,500.00	15,580.00	10,420.00	5,000.00
Nbr of stocks (in thousands)	1,785	1,785	1,785	3,309	10,038	11,038
Announcement Date	15/3/21	14/3/22	17/3/23	13/3/24	14/3/25	20/3/26

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
APTOCROM INC.	-	-	-	-	20.63M
ELI LILLY AND COMPANY	33.65x	12.19x	24.78x	0.59%	1,056B
JOHNSON & JOHNSON	30.17x	6.71x	18.78x	1.98%	655B
ABBVIE INC.	33.43x	7.82x	16.17x	2.59%	471B
ROCHE HOLDING AG	19.59x	4.78x	11.84x	2.78%	342B
NOVARTIS AG	20.4x	5.31x	13.17x	3.01%	277B
ASTRAZENECA PLC	21.19x	4.39x	12.5x	2.01%	257B
AMGEN INC.	26.19x	6.82x	12.15x	2.43%	226B
GILEAD SCIENCES, INC.	-45.65x	6.64x	25.94x	2.18%	189B
NOVO NORDISK A/S	11.33x	4.13x	8.58x	4.44%	170B
Average	16.70x	6.53x	15.99x	2.45%	364.29B
Weighted average by Cap.	24.17x	7.87x	18.15x	1.96%